SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

YIELD10 Bioscience, Inc. – ‘10-Q’ for 9/30/22 – ‘EX-101.SCH’

On:  Monday, 11/14/22, at 4:14pm ET   ·   For:  9/30/22   ·   Accession #:  1121702-22-49   ·   File #:  1-33133

Previous ‘10-Q’:  ‘10-Q’ on 8/10/22 for 6/30/22   ·   Next:  ‘10-Q’ on 5/12/23 for 3/31/23   ·   Latest:  ‘10-Q’ on 11/14/23 for 9/30/23   ·   3 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

11/14/22  YIELD10 Bioscience, Inc.          10-Q        9/30/22   60:4.8M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.02M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     21K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     21K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
10: R1          Cover                                               HTML     69K 
11: R2          Condensed Consolidated Statements of Operations     HTML     85K 
                Unaudited                                                        
12: R3          Condensed Consolidated Balance Sheets Unaudited     HTML    112K 
13: R4          Condensed Consolidated Balance Sheets               HTML     35K 
                (Parenthetical)                                                  
14: R5          Condensed Consolidated Statements of Comprehensive  HTML     44K 
                Loss Unaudited                                                   
15: R6          Condensed Consolidated Statements of Cash Flows     HTML     89K 
                Unaudited                                                        
16: R7          Condensed Consolidated Statements of Stockholders'  HTML     81K 
                Equity                                                           
17: R8          Accounting Policies                                 HTML     51K 
18: R9          Nature of Business and Basis of Presentation        HTML     32K 
19: R10         Basic and Diluted Net Loss Per Share                HTML     28K 
20: R11         Investments                                         HTML     37K 
21: R12         Fair Value Measurements                             HTML     50K 
22: R13         Accrued Expenses                                    HTML     27K 
23: R14         Stock-Based Compensation                            HTML     37K 
24: R15         Leases                                              HTML     46K 
25: R16         Commitments and Contingencies                       HTML     27K 
26: R17         License Agreements                                  HTML     21K 
27: R18         Geographic Information                              HTML     42K 
28: R19         Capital Stock and Warrants                          HTML     42K 
29: R20         Accounting Policies (Policies)                      HTML     93K 
30: R21         Accounting Policies (Tables)                        HTML     37K 
31: R22         Basic and Diluted Net Loss Per Share (Tables)       HTML     26K 
32: R23         Investments (Tables)                                HTML     36K 
33: R24         Fair Value Measurements (Tables)                    HTML     47K 
34: R25         Accrued Expenses (Tables)                           HTML     26K 
35: R26         Stock-Based Compensation (Tables)                   HTML     35K 
36: R27         Leases (Tables)                                     HTML     44K 
37: R28         Geographic Information (Tables)                     HTML     39K 
38: R29         Capital Stock and Warrants (Tables)                 HTML     43K 
39: R30         ACCOUNTING POLICIES - Additional Information        HTML     35K 
                (Details)                                                        
40: R31         ACCOUNTING POLICIES - Schedule of Cash And          HTML     27K 
                Restricted Cash (Details)                                        
41: R32         Nature of Business and Basis of Presentation        HTML     20K 
                (Details)                                                        
42: R33         Basic and Diluted Net Loss Per Share (Details)      HTML     27K 
43: R34         Investments (Details)                               HTML     30K 
44: R35         FAIR VALUE MEASUREMENTS - Assets and Liabilities    HTML     45K 
                Measured at Fair Value on a Recurring Basis                      
                (Details)                                                        
45: R36         Accrued Expenses (Details)                          HTML     29K 
46: R37         Stock-Based Compensation (Details)                  HTML     82K 
47: R38         Stock-Based Compensation - RSU Activity (Details)   HTML     28K 
48: R39         LEASES - Narrative (Details)                        HTML     31K 
49: R40         LEASES - Maturity Analysis of Lease Liabilities     HTML     38K 
                (Details)                                                        
50: R41         LEASES - Quantitative Disclosure of Lease Costs     HTML     33K 
                (Details)                                                        
51: R42         Commitments and Contingencies (Details)             HTML     32K 
52: R43         Geographic Information (Details)                    HTML     31K 
53: R44         CAPITAL STOCK AND WARRANTS - Narrative (Details)    HTML     39K 
54: R45         CAPITAL STOCK AND WARRANTS - Schedule Of Warrants   HTML     34K 
                Issuance (Details)                                               
55: R46         CAPITAL STOCK AND WARRANTS - Schedule of Common     HTML     25K 
                Stock Reserved For Future Issuance (Details)                     
58: XML         IDEA XML File -- Filing Summary                      XML    103K 
56: XML         XBRL Instance -- yten-20220930_htm                   XML   1.11M 
57: EXCEL       IDEA Workbook of Financial Reports                  XLSX    100K 
 6: EX-101.CAL  XBRL Calculations -- yten-20220930_cal               XML    135K 
 7: EX-101.DEF  XBRL Definitions -- yten-20220930_def                XML    311K 
 8: EX-101.LAB  XBRL Labels -- yten-20220930_lab                     XML   1.05M 
 9: EX-101.PRE  XBRL Presentations -- yten-20220930_pre              XML    584K 
 5: EX-101.SCH  XBRL Schema -- yten-20220930                         XSD     96K 
59: JSON        XBRL Instance as JSON Data -- MetaLinks              296±   448K 
60: ZIP         XBRL Zipped Folder -- 0001121702-22-000049-xbrl      Zip    259K

‘EX-101.SCH’   —   XBRL Schema — yten-20220930

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- XBRL Document Created with Wdesk from Workiva -->
<!-- Copyright 2022 Workiva -->
<!-- r:d1317484-fb72-4a35-a936-0de0909d8212,g:44a95c54-f659-440a-9ac9-343c03dbcc39 -->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:yten="http://www.yield10bio.com/20220930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.yield10bio.com/20220930">
<xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
<xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
<xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
<xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
<xs:annotation>
<xs:appinfo>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="yten-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="yten-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="yten-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="yten-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:roleType id="Cover" roleURI="http://www.yield10bio.com/role/Cover">
<link:definition> 0000001 - Document - Cover </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" roleURI="http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED">
<link:definition> 0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS UNAUDITED </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" roleURI="http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED">
<link:definition> 0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS UNAUDITED </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
<link:definition> 0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUNAUDITED" roleURI="http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUNAUDITED">
<link:definition> 0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS UNAUDITED </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" roleURI="http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED">
<link:definition> 0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS UNAUDITED </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
<link:definition> 0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ACCOUNTINGPOLICIES" roleURI="http://www.yield10bio.com/role/ACCOUNTINGPOLICIES">
<link:definition> 0000008 - Disclosure - ACCOUNTING POLICIES </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="NATUREOFBUSINESSANDBASISOFPRESENTATION" roleURI="http://www.yield10bio.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION">
<link:definition> 0000009 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BASICANDDILUTEDNETLOSSPERSHARE" roleURI="http://www.yield10bio.com/role/BASICANDDILUTEDNETLOSSPERSHARE">
<link:definition> 0000010 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="INVESTMENTS" roleURI="http://www.yield10bio.com/role/INVESTMENTS">
<link:definition> 0000011 - Disclosure - INVESTMENTS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTS">
<link:definition> 0000012 - Disclosure - FAIR VALUE MEASUREMENTS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ACCRUEDEXPENSES" roleURI="http://www.yield10bio.com/role/ACCRUEDEXPENSES">
<link:definition> 0000013 - Disclosure - ACCRUED EXPENSES </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://www.yield10bio.com/role/STOCKBASEDCOMPENSATION">
<link:definition> 0000014 - Disclosure - STOCK-BASED COMPENSATION </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LEASES" roleURI="http://www.yield10bio.com/role/LEASES">
<link:definition> 0000015 - Disclosure - LEASES </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.yield10bio.com/role/COMMITMENTSANDCONTINGENCIES">
<link:definition> 0000016 - Disclosure - COMMITMENTS AND CONTINGENCIES </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LICENSEAGREEMENTS" roleURI="http://www.yield10bio.com/role/LICENSEAGREEMENTS">
<link:definition> 0000017 - Disclosure - LICENSE AGREEMENTS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="GEOGRAPHICINFORMATION" roleURI="http://www.yield10bio.com/role/GEOGRAPHICINFORMATION">
<link:definition> 0000018 - Disclosure - GEOGRAPHIC INFORMATION </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CAPITALSTOCKANDWARRANTS" roleURI="http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTS">
<link:definition> 0000019 - Disclosure - CAPITAL STOCK AND WARRANTS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ACCOUNTINGPOLICIESPolicies" roleURI="http://www.yield10bio.com/role/ACCOUNTINGPOLICIESPolicies">
<link:definition> 0000020 - Disclosure - ACCOUNTING POLICIES (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ACCOUNTINGPOLICIESTables" roleURI="http://www.yield10bio.com/role/ACCOUNTINGPOLICIESTables">
<link:definition> 0000021 - Disclosure - ACCOUNTING POLICIES (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BASICANDDILUTEDNETLOSSPERSHARETables" roleURI="http://www.yield10bio.com/role/BASICANDDILUTEDNETLOSSPERSHARETables">
<link:definition> 0000022 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="INVESTMENTSTables" roleURI="http://www.yield10bio.com/role/INVESTMENTSTables">
<link:definition> 0000023 - Disclosure - INVESTMENTS (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSTables">
<link:definition> 0000024 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ACCRUEDEXPENSESTables" roleURI="http://www.yield10bio.com/role/ACCRUEDEXPENSESTables">
<link:definition> 0000025 - Disclosure - ACCRUED EXPENSES (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="STOCKBASEDCOMPENSATIONTables" roleURI="http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONTables">
<link:definition> 0000026 - Disclosure - STOCK-BASED COMPENSATION (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LEASESTables" roleURI="http://www.yield10bio.com/role/LEASESTables">
<link:definition> 0000027 - Disclosure - LEASES (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="GEOGRAPHICINFORMATIONTables" roleURI="http://www.yield10bio.com/role/GEOGRAPHICINFORMATIONTables">
<link:definition> 0000028 - Disclosure - GEOGRAPHIC INFORMATION (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CAPITALSTOCKANDWARRANTSTables" roleURI="http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSTables">
<link:definition> 0000029 - Disclosure - CAPITAL STOCK AND WARRANTS (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ACCOUNTINGPOLICIESAdditionalInformationDetails" roleURI="http://www.yield10bio.com/role/ACCOUNTINGPOLICIESAdditionalInformationDetails">
<link:definition> 0000030 - Disclosure - ACCOUNTING POLICIES - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ACCOUNTINGPOLICIESScheduleofCashAndRestrictedCashDetails" roleURI="http://www.yield10bio.com/role/ACCOUNTINGPOLICIESScheduleofCashAndRestrictedCashDetails">
<link:definition> 0000031 - Disclosure - ACCOUNTING POLICIES - Schedule of Cash And Restricted Cash (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails" roleURI="http://www.yield10bio.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails">
<link:definition> 0000032 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BASICANDDILUTEDNETLOSSPERSHAREDetails" roleURI="http://www.yield10bio.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails">
<link:definition> 0000033 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="INVESTMENTSDetails" roleURI="http://www.yield10bio.com/role/INVESTMENTSDetails">
<link:definition> 0000034 - Disclosure - INVESTMENTS (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" roleURI="http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails">
<link:definition> 0000035 - Disclosure - FAIR VALUE MEASUREMENTS - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ACCRUEDEXPENSESDetails" roleURI="http://www.yield10bio.com/role/ACCRUEDEXPENSESDetails">
<link:definition> 0000036 - Disclosure - ACCRUED EXPENSES (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="STOCKBASEDCOMPENSATIONDetails" roleURI="http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONDetails">
<link:definition> 0000037 - Disclosure - STOCK-BASED COMPENSATION (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="STOCKBASEDCOMPENSATIONRSUActivityDetails" roleURI="http://www.yield10bio.com/role/STOCKBASEDCOMPENSATIONRSUActivityDetails">
<link:definition> 0000038 - Disclosure - STOCK-BASED COMPENSATION - RSU Activity (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LEASESNarrativeDetails" roleURI="http://www.yield10bio.com/role/LEASESNarrativeDetails">
<link:definition> 0000039 - Disclosure - LEASES - Narrative (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LEASESMaturityAnalysisofLeaseLiabilitiesDetails" roleURI="http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails">
<link:definition> 0000040 - Disclosure - LEASES - Maturity Analysis of Lease Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LEASESQuantitativeDisclosureofLeaseCostsDetails" roleURI="http://www.yield10bio.com/role/LEASESQuantitativeDisclosureofLeaseCostsDetails">
<link:definition> 0000041 - Disclosure - LEASES - Quantitative Disclosure of Lease Costs (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://www.yield10bio.com/role/COMMITMENTSANDCONTINGENCIESDetails">
<link:definition> 0000042 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="GEOGRAPHICINFORMATIONDetails" roleURI="http://www.yield10bio.com/role/GEOGRAPHICINFORMATIONDetails">
<link:definition> 0000043 - Disclosure - GEOGRAPHIC INFORMATION (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CAPITALSTOCKANDWARRANTSNarrativeDetails" roleURI="http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSNarrativeDetails">
<link:definition> 0000044 - Disclosure - CAPITAL STOCK AND WARRANTS - Narrative (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CAPITALSTOCKANDWARRANTSScheduleOfWarrantsIssuanceDetails" roleURI="http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleOfWarrantsIssuanceDetails">
<link:definition> 0000045 - Disclosure - CAPITAL STOCK AND WARRANTS - Schedule Of Warrants Issuance (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CAPITALSTOCKANDWARRANTSScheduleofCommonStockReservedForFutureIssuanceDetails" roleURI="http://www.yield10bio.com/role/CAPITALSTOCKANDWARRANTSScheduleofCommonStockReservedForFutureIssuanceDetails">
<link:definition> 0000046 - Disclosure - CAPITAL STOCK AND WARRANTS - Schedule of Common Stock Reserved For Future Issuance (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
</xs:appinfo>
</xs:annotation>
<xs:element id="yten_LeaseOtherInformationAbstract" abstract="true" name="LeaseOtherInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
<xs:element id="yten_ClassOfWarrantOrRightExpired" abstract="false" name="ClassOfWarrantOrRightExpired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
<xs:element id="yten_CollaborativeArrangementTermOfOptionForLicenseAgreement" abstract="false" name="CollaborativeArrangementTermOfOptionForLicenseAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
<xs:element id="yten_PublicOfferingMember" abstract="true" name="PublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="yten_CollaborativeArrangementQuarterlyResearchFundingAndOptionFeesPayable" abstract="false" name="CollaborativeArrangementQuarterlyResearchFundingAndOptionFeesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="yten_IncreaseDecreaseInLeaseLiabilities" abstract="false" name="IncreaseDecreaseInLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="yten_EmployeeAndDirectorsStockOptionsMember" abstract="true" name="EmployeeAndDirectorsStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="yten_WarrantExpiringSeptember2024Member" abstract="true" name="WarrantExpiringSeptember2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="yten_LesseeOperatingSubleaseSubleasedArea" abstract="false" name="LesseeOperatingSubleaseSubleasedArea" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:areaItemType"/>
<xs:element id="yten_CostOfRevenueResearchAndDevelopmentExpenses" abstract="false" name="CostOfRevenueResearchAndDevelopmentExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="yten_OperatingLeaseLiabilityNoncurrentExcludingLeaseIncludedOnBalanceSheet" abstract="false" name="OperatingLeaseLiabilityNoncurrentExcludingLeaseIncludedOnBalanceSheet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="yten_PresidentialWayWoburnMassachusettsMember" abstract="true" name="PresidentialWayWoburnMassachusettsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="yten_PaymentTaxWithholdingShareBasedPaymentArrangementExcludingEmployerAmount" abstract="false" name="PaymentTaxWithholdingShareBasedPaymentArrangementExcludingEmployerAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="yten_IntellectualPropertyCostsPolicyTextBlock" abstract="false" name="IntellectualPropertyCostsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
<xs:element id="yten_WarrantExpiringJanuary2024Member" abstract="true" name="WarrantExpiringJanuary2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="yten_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
<xs:element id="yten_ProceedsFromWarrantExercisesNet" abstract="false" name="ProceedsFromWarrantExercisesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="yten_SeriesBWarrantExpiringMay2027Member" abstract="true" name="SeriesBWarrantExpiringMay2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="yten_GrainProductionGuaranteedPaymentsMember" abstract="true" name="GrainProductionGuaranteedPaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="yten_CollaborativeArrangementResearchFundingAndOptionFeesPayable" abstract="false" name="CollaborativeArrangementResearchFundingAndOptionFeesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="yten_AccountsReceivableAfterAllowanceForCreditLossCurrentAndUnbilledContractsReceivable" abstract="false" name="AccountsReceivableAfterAllowanceForCreditLossCurrentAndUnbilledContractsReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="yten_A410DowneyRoadAnd110GymnasiumPlaceMember" abstract="true" name="A410DowneyRoadAnd110GymnasiumPlaceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="yten_SeriesAWarrantExpiringDecember2022Member" abstract="true" name="SeriesAWarrantExpiringDecember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="yten_MichiganStateUniversityMember" abstract="true" name="MichiganStateUniversityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="yten_NoncashLeaseExpenseIncome" abstract="false" name="NoncashLeaseExpenseIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="yten_ChargeForCompanyCommonStockMatch" abstract="false" name="ChargeForCompanyCommonStockMatch" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="yten_AccruedLeaseCost" abstract="false" name="AccruedLeaseCost" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="yten_CollaborativeArrangementTerm" abstract="false" name="CollaborativeArrangementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
<xs:element id="yten_CJCheilJedangCorporationMember" abstract="true" name="CJCheilJedangCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="yten_ClassOfWarrantOrRightExercised" abstract="false" name="ClassOfWarrantOrRightExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
<xs:element id="yten_LicensingAgreementsTextBlock" abstract="false" name="LicensingAgreementsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
<xs:element id="yten_AccruedFieldTrialsAndRelatedExpensesCurrent" abstract="false" name="AccruedFieldTrialsAndRelatedExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="yten_GainOnRelatedPartyInvestment" abstract="false" name="GainOnRelatedPartyInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/24/23  YIELD10 Bioscience, Inc.          424B5                  1:587K

2 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/11/22  YIELD10 Bioscience, Inc.          10-Q        3/31/22   59:4.5M
 3/25/22  YIELD10 Bioscience, Inc.          10-K       12/31/21   83:9.4M
↑Top
Filing Submission 0001121702-22-000049   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., Apr. 30, 4:23:39.2am ET